Výsledky vyhledávání - Jun‐ichi Nishimura
- Zobrazuji výsledky 1 - 15 z 15
-
1
-
2
-
3
-
4
Inefficient response of T lymphocytes to glycosylphosphatidylinositol anchor–negative cells: implications for paroxysmal nocturnal hemoglobinuria Autor Yoshiko Murakami, Hiroshi Kosaka, Yusuke Maeda, Jun‐ichi Nishimura, Norimitsu Inoue, Kazuhito Ohishi, Masaru Okabe, Junji Takeda, Taroh Kinoshita
Vydáno 2002Artigo -
5
A Patient With Paroxysmal Nocturnal Hemoglobinuria Bearing Four Independent PIG-A Mutant Clones Autor Jun‐ichi Nishimura, Norimitsu Inoue, Hiroshi Wada, E Ueda, Patcharin Pramoonjago, Toshiyuki Hirota, Takashi Machii, Takashi Kageyama, Akihisa Kanamaru, Junji Takeda, Taroh Kinoshita, Teruo Kitani
Vydáno 1997Artigo -
6
Long‐term safety and efficacy of ravulizumab in patients with paroxysmal nocturnal hemoglobinuria: 2‐year results from two pivotal phase 3 studies Autor Austin Kulasekararaj, Morag Griffin, Saskia Langemeijer, Kensuke Usuki, Alexander Kulagin, Masayo Ogawa, Ji Yu, Arshad Mujeebuddin, Jun‐ichi Nishimura, Jong Wook Lee, Régis Peffault de Latour
Vydáno 2022Artigo -
7
Diagnosis and management of paroxysmal nocturnal hemoglobinuria Autor Charles Parker, Mitsuhiro Omine, Stephen J. Richards, Jun‐ichi Nishimura, Monica Bessler, Russell E. Ware, Peter Hillmen, Lucio Luzzatto, Neal S. Young, Taroh Kinoshita, Wendell Rosse, Gerard Socié
Vydáno 2005Revisão -
8
Use of the complement inhibitor Coversin to treat HSCT-associated TMA Autor Timothy H.J. Goodship, Fernando Pinto, Wynn H. Weston-Davies, Juliana Silva, Jun‐ichi Nishimura, Miles A. Nunn, Ian Mackie, Samuel J. Machin, Liina Palm, Jeremy Pryce, Robert Chiesa, Persis Amrolia, Paul Veys
Vydáno 2017Artigo -
9
Clinical Course and Flow Cytometric Analysis of Paroxysmal Nocturnal Hemoglobinuria in the United States and Japan Autor Jun‐ichi Nishimura, Yuzuru Kanakura, Russell E. Ware, Tsutomu Shichishima, Hideki Nakakuma, Haruhiko Ninomiya, Carlos M. DeCastro, Sharon Hall, Akihisa Kanamaru, Keith M. Sullivan, Hideaki Mizoguchi, Mitsuhiro Omine, Taroh Kinoshita, Wendell F. Rosse
Vydáno 2004Artigo -
10
P772: LONG-TERM RAVULIZUMAB TREATMENT IN COMPLEMENT INHIBITOR-EXPERIENCED PATIENTS WITH PNH PROVIDES DURABLE CONTROL OF INTRAVASCULAR HEMOLYSIS WITH LOW INCIDENCE OF MAJOR ADVERSE... Autor Austin Kulasekararaj, Robert A. Brodsky, Morag Griffin, Alexander Röth, Caroline I. Piatek, Masayo Ogawa, Ji Yu, Yogesh Patel, Fernando Ataúlfo González Fernández, Jun‐ichi Nishimura, Régis Peffault de Latour, Jeff Szer, Jong Wook Lee
Vydáno 2023Artigo -
11
Molecular basis of clonal expansion of hematopoiesis in 2 patients with paroxysmal nocturnal hemoglobinuria (PNH) Autor Naoya Inoue, T. Izui-Sarumaru, Yoshiko Murakami, Yushiro Endo, Jun‐ichi Nishimura, Ken Kurokawa, Miyuki Kuwayama, Hiroaki Shime, Takashi Machii, Yuzuru Kanakura, Gabrielle Meyers, Carl T. Wittwer, Zhiqiang Chen, Wayne D. Babcock, Debra Frei‐Lahr, Charles J. Parker, Taroh Kinoshita
Vydáno 2006Artigo -
12
Complement and inflammasome overactivation mediates paroxysmal nocturnal hemoglobinuria with autoinflammation Autor Britta Höchsmann, Yoshiko Murakami, Makiko Osato, Alexej Knaus, Michi Kawamoto, Norimitsu Inoue, Tetsuya Hirata, Shogo Murata, Markus Anliker, Thomas Eggermann, Marten Jäger, Ricarda Floettmann, Alexander Höllein, Sho Murase, Yasutaka Ueda, Jun‐ichi Nishimura, Yuzuru Kanakura, Nobuo Kohara, Hubert Schrezenmeier, Peter Krawitz, Taroh Kinoshita
Vydáno 2019Artigo -
13
Pharmacokinetic characterization and exposure–response relationship of crovalimab in the COMMODORE 1, 2 and 3 and COMPOSER trials of patients with paroxysmal nocturnal haemoglobinu... Autor Valérie Cosson, Rong Fu, Austin Kulasekararaj, Jun‐ichi Nishimura, Jens Panse, Alexander Röth, Phillip Scheinberg, Hongyan Tong, Sung‐Soo Yoon, Leigh Beveridge, Keisuke Gotanda, Félix Jaminion, Andrea Henrich, Pontus Lundberg, Dayu Shi, Sasha Sreckovic, Yuchen Zhang, Zilu Zhang, Khaled Benkali, Simon Buatois
Vydáno 2025Artigo -
14
Genetic Variants in C5 and Poor Response to Eculizumab Autor Jun‐ichi Nishimura, Masaki Yamamoto, Shin Hayashi, Kazuma Ohyashiki, Kiyoshi Ando, Andrés Brodsky, Hideyoshi Noji, Kunio Kitamura, Tetsuya Eto, Toru TAKAHASHI, Masayoshi Masuko, Takuro Matsumoto, Yuji Wano, Tsutomu Shichishima, Hirohiko Shibayama, Masakazu Hase, Lan Li, Krista Johnson, Alberto Lazarowski, Paul P. Tamburini, Johji Inazawa, Taroh Kinoshita, Yuzuru Kanakura
Vydáno 2014Artigo -
15
Phase 3 randomized <scp>COMMODORE</scp> 2 trial: Crovalimab versus eculizumab in patients with <scp>paroxysmal nocturnal hemoglobinuria</scp> naive to complement inhibition Autor Alexander Röth, Guangsheng He, Hongyan Tong, Zenghua Lin, Xiaoqin Wang, Chatree Chai‐Adisaksopha, Je‐Hwan Lee, Andrés Brodsky, Chattree Hantaweepant, Teresita Dumagay, Roberta Demichelis‐Gómez, Ponlapat Rojnuckarin, Jing Sun, Martin Höglund, Jun Ho Jang, Anna Gayà, Fernando Silva, Naoshi Obara, Richard J. Kelly, Leigh Beveridge, Simon Buatois, Sammy Chebon, Brittany Gentile, Pontus Lundberg, Sasha Sreckovic, Jun‐ichi Nishimura, Antonio M. Risitano, Bing Han
Vydáno 2024Artigo
Vyhledávací nástroje:
Související témata
Immunology
Paroxysmal nocturnal hemoglobinuria
Medicine
Complement system
Antibody
Biology
Genetics
Eculizumab
Gene
Hemoglobinuria
Internal medicine
Anemia
Bone marrow
Gastroenterology
Haematopoiesis
Stem cell
Adverse effect
Biochemistry
Complementation
Hemolysis
Molecular biology
Mutation
Antigen
Aplastic anemia
CD59
Cell biology
Chemistry
Complement (music)
Complement component 5
Dosing